Bank Of Montreal Vigil Neuroscience, Inc. Transaction History

Bank Of Montreal

  • $197 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.68 - $3.63 $89,426 - $121,125
33,368 New
33,368 $113,000
Q2 2023

Aug 02, 2023
BUY
$8.11 - $10.54 $122,809 - $159,607
15,143 Added 26.06%
73,243 $688,000
Q1 2023

Jun 13, 2024
BUY
$8.77 - $12.7 $69,502 - $100,647
7,925 Added 23.75%
41,293 $404,000
Q4 2022

Feb 01, 2023
BUY
$8.74 - $15.99 $507,794 - $929,019
58,100 New
58,100 $726,000

Others Institutions Holding VIGL

# of Institutions
58
Shares Held
26.3M
Call Options Held
0
Put Options Held
0
View Full List

About Vigil Neuroscience, Inc.

VIGL Quotes by TradingView
  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $93.6M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email